Allerject Epi Pen Recall

Sanofi Canada Issues Voluntary Nationwide Recall of Allerject® Due to Potential Inaccurate Dosage Delivery Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on the market and includes both the 0.15 mg/ 0.15 mL and 0.3 mg/0.3 mL strengths for hospitals, retailers and consumers. The products have been found to potentially have inaccurate dosage delivery. If a patient who is experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the… Read More

in: General